DJO Has Completed the Acquisition of STAR Ankle and Finger Arthroplasty Systems

November 12, 2020

DJO, LLC (DJO or the Company), a leading global provider of medical technologies to get and keep people moving, today announced that it has completed the acquisition of total ankle and finger arthroplasty product lines from international medical technology company Stryker.

DJO notes the acquisition includes the STAR® total ankle arthroplasty system, a preferred technology worldwide because of its deep and leading clinical outcomes research,1-9 along with Silicone, Surface Replacement (SR) and TACTYS® finger joint arthroplasty products, one of the world’s most comprehensive finger joint arthroplasty portfolios.

Ankle replacements in the U.S. more than doubled last year, in part because ankle implants are becoming the treatment of choice over fusion surgery.10 The STAR ankle is a mobile-bearing total ankle replacement in the U.S. market approved for uncemented use, making it a preferred choice for surgeons and patients who want to help restore mobility.

“Ankle and finger arthroplasty are two fast-growing arthroplasty segments, and this acquisition reflects DJO’s focus on providing market-leading solutions to meet the greater needs of surgeons and their patients,” said Brady Shirley, CEO of DJO®. “This expansion allows us to address a larger patient population and enhances our goal of helping patients return to an active lifestyle.”

SourceDJO

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”